TOPOTARGET
TopoTarget is helpful to merged with Onxeo and development of drugs for orphan oncology diseases and Topotarget of oncology products.
TOPOTARGET
Industry:
Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.topotarget.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Domain Not Resolving MarkMonitor DNS ScanNet
Official Site Inspections
http://www.topotarget.com
- Host name: 64.190.63.222
- IP address: 64.190.63.222
- Location: Cleveland United States
- Latitude: 41.5043
- Longitude: -81.6786
- Metro Code: 510
- Timezone: America/New_York
- Postal: 44114

More informations about "TopoTarget"
TopoTarget - Crunchbase Company Profile & Funding
TopoTarget Switzerland has develops oncology and immunology products. The companyโs products include APO866, a small molecule therapeutic for the โฆSee details»
Topotarget 2025 Company Profile: Valuation, Investors ... - PitchBook
Topotarget was founded in 2000. Where is Topotarget headquartered? Topotarget is headquartered in Copenhagen, Denmark. What is the size of Topotarget? Topotarget has 13 โฆSee details»
TopoTarget A/S - Kopenhagen, Denmark - bionity.com
TopoTarget was formed in 2000 in Copenhagen, and is headquartered in Denmark with subsidiaries in the US, Switzerland, Germany and the UK. The company completed a โฆSee details»
BioAlliance Pharma, Topotarget to form Onxeo - Drug Discovery โฆ
PARIS & COPENHAGEN, DenmarkโBioAlliance Pharma SA and Topotarget A/S have announced a definitive merger agreement to combine their companies under the new name of โฆSee details»
TopoTarget A/S
TopoTarget (CSE: TOPO) is a fully integrated biopharmaceutical company with facilities in Denmark, UK and Germany dedicated to finding โโAnswers for Cancerโโ The company โฆSee details»
TopoTarget Switzerland S.A. - Lausanne, Switzerland - bionity.com
Most recently, TopoTarget added two cancer products in clinical development to its pipeline following the acquisition in June 2007 of a Swiss company, now TopoTarget Switzerland SA. โฆSee details»
Topotarget A/S (OMX: TOPO) - life-sciences-europe.com
Nov 1, 2000 Topotarget (NASDAQ OMX: TOPO) is a Scandinavian based international biotech company headquartered in Denmark, dedicated to improve cancer therapies. In collaboration โฆSee details»
TopoTarget A/S - VentureRadar
TopoTarget is a biopharmaceutical company developing novel cancer drugs. TopoTarget has several programs ranging from late stage niche compounds to earlier stage compounds, in โฆSee details»
Topotarget A/S - Drug pipelines, Patents, Clinical trials - Synapse
Last update 23 Jan 2025. Topotarget A/S. Private Company |See details»
Onxeo acquires TopoTarget - 2007-06-27 - Crunchbase
Jun 27, 2007 Acquired Organization: TopoTarget TopoTarget focused on the discovery and development of drugs and therapies to treat cancer. Acquiring Organization: Onxeo Onxeo is a โฆSee details»
TopoTarget - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Feb 2, 2025 TopoTarget focused on the discovery and development of drugs and therapies to treat cancer.See details»
BioAlliance Pharma, TopoTarget A/S to Merge - Drug โฆ
The merger plan confirmed the terms of the merger agreement announced on April 16, 2014, whereby the continuing entity will be BioAlliance Pharma and the exchange ratio of two newly โฆSee details»
TopoTarget A/S - VentureRadar
Similar Companies: Tepnel Life Sciences United Kingdom n/a Tepnel Life Sciences is a leading provider of nucleic acid purification solutions to the BioMedical research market. Its range โฆSee details»
BioAlliance Pharma Buying Topotarget, Adding Potential โฆ
Apr 16, 2014 The merger with Topotarget will strengthen and diversify our position in rare oncology diseases,โ Patrick Langlois, chairman of the Board of Directors of BioAlliance โฆSee details»
TopoTarget UK Limited - Crunchbase Company Profile & Funding
TopoTarget UK Limited is discovers and develops drugs for the treatment of proliferative diseases. It focuses on discovering drugs for the treatment of cancer. ... 819 Number of โฆSee details»
BioAlliance and Topotarget plan to merge, pooling their cancer ...
Apr 16, 2014 "Topotarget is managed by a highly experienced team of executives, and the merger will enable both teams to combine their respective expertise to create a new company โฆSee details»
BioAlliance Pharma and Topotarget join forces to create new โฆ
Apr 16, 2014 Topotarget CEO Anders Vadsholt noted that the positioning of BioAlliance Pharma, their late stage assets and expertise makes BioAlliance Pharma a perfect fit as a company to โฆSee details»
TopoTarget - Crunchbase
TopoTarget focused on the discovery and development of drugs and therapies to treat cancer.See details»
From traditional algorithms to artificial intelligence: a review of the ...
14 hours ago This review investigates trends in the development of image sonification methods applied in visual-to-auditory sensory substitution systems. The authors consider both โฆSee details»
Key Cybersecurity Challenges In 2025โTrends And Observations
1 day ago A recent report from Proofpoint found 92% of healthcare organizations reported experiencing a cyberattack in 2024, up from 88% in 2023, while the average cost of the most โฆSee details»